Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000841

Drug Information
NameTestosterone    
SynonymsD00075; Cristerona T; Synandrol F; Mertestate; Orquisteron; Andropatch; Testosterone; 4-Androsten-17?-ol-3-one; 17?-Hydroxy-4-androsten-3-one; HMS2052N11; Homosteron; Testim (TN); Testobase; Depotest; Halotensin; UNII-3XMK78S47O; Androst-4-en-3-one, 17-hydroxy-, (17beta)-; Andrusol; 4-Androsten-17beta-ol-3-one; NCGC00091018-01; DB00624; Neo-Hombreol F; Virormone; CPD000058344; T1500_SIGMA; Scheinpharm Testone-Cyp; S00309; MLS000563091; Testaqua; NSC 9700; Sustanon; Sustason 250; Testosterona; Testoject-50; Testosterone [INN:BAN]; Percutacrine androgenique; Testosteroid; Testosterone hydrate; 17beta-Hydroxy-delta(sup4)-androsten-3-one; Testostosterone; delta4-androsten-17b-ol-3-one; Perandren; 17beta-Hydroxyandrost-4-en-3-one; T5411_FLUKA; Testoviron T; Oreton-F; 17-beta-Hydroxy-delta(sup 4)-androsten-3-one; Testosteron; Androst-4-en-3-one, 17-beta-hydroxy-; Testolin; MolPort-002-506-901; 17beta-Hydroxyandrost-4-ene-3-one; Testoviron Schering; Primoteston; Primotest; SMR000058344; (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; Testro AQ; BIDD:ER0555; Oreton F; MLS001306401; Androst-4-en-3-one, 17-hydroxy, (17.beta.)-; Neotestis; Testopel Pellets; EINECS 200-370-5; 46923_FLUKA; CDB 111C; Geno-cristaux gremy; Testrin-P.A; Relibra; LS-148813; Sustanone; Virosterone; Malestrone (amps); Homosterone; 46923_RIEDEL; Androst-4-en-3-one, 17beta-hydroxy-; Andropository 200; AC1L1LM0; Androgel (TN); Andro 100; Testosteronum; Testim; SMR001261453; 17-beta-Hydroxyandrost-4-en-3-one; Androderm; Malogen in Oil; COL 1621; Striant; 4-androstene-17beta-ol-3-one; AndroGel; Neo-testis; Androst-4-en-17beta-ol-3-one; 17-Hydroxy-(17beta)-androst-4-en-3-one; (17beta)-17-Hydroxyandrost-4-en-3-one; C00535; Testosteronum [INN-Latin]; Testogel; Testiculosterone; trans-Testosterone; Testosterone solution; BIM-0061761.0001; 17b-hydroxy-4-androsten-3-one; LibiGel; Androst-4-en-3-one, 17-hydroxy-, (17-beta)-; Testosterone [Androgenic steroids, anabolic]; Teslen; Testosterone and its esters; MLS001032098; 7-beta-Hydroxyandrost-4-en-3-one; Testred Cypionate 200; 17-Hydroxy-(17-beta)-androst-4-en-3-one; Testosterona [INN-Spanish]; S2033_Selleck; testosterone; 58-22-0; Andryl 200; CID6013; Cristerone T; AC-14899; Oreton; CMC_13449; Andronaq; CP 601B; ZINC06500184; Testosterone (JAN/USP); Virilon IM; 17beta-Hydroxy-3-oxo-4-androstene; SAM001246921; Testrone; Bio-0678; Testoviron; beta testosterone; T-Cypionate; Intrinsa; CHEMBL386630; 17beta-Hydroxy-4-androsten-3-one; Malerone; Andronate 200; B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E; CCRIS 574; delta4-Androsten-17beta-ol-3-one; Testoderm; Androderm (TN); T5411_SIGMA; Testopropon; HSDB 3398; Testamone 100; AA 2500; Everone 200; Testoderm Tts; LMST02020002; Malogen, aquaspension injection; Testryl; delta(sup 4)-Androsten-17(beta)-ol-3-one; Andronate 100; Striant (TN); Androsorb; Testandrone; MLS002174283; CHEBI:17347; Androlin    
IndicationReplacement therapy and osteoporosisApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAndrogens    
CAS NumberCAS 58-22-0
FormularC19H28O2    
PubChem Compound IDCID 6013.    
PubChem Substance IDSID 3817.    
ChEBI17347;    
SuperDrug ATC IDG03BA03;    
SuperDrug CAS ID000057852;    
TargetAndrogen receptorAgonist[2][3]
Ref 1Emerging drugs for hypogonadism. Expert Opin Emerg Drugs. 2006 Nov;11(4):685-707. To Reference
Ref 2Molecular mechanism of androgen action. Trends Endocrinol Metab. 1998 Oct 1;9(8):317-24. To Reference
Ref 3Complexities of androgen action. J Am Acad Dermatol. 2001 Sep;45(3 Suppl):S87-94. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543